Conclusions Day 100 NKC/CD14+HLA-DRDIM ratio is a prognostic immune-biomarker in lymphoma patients post- APBHSCT.Luis F. PorrataStephen M. AnsellIvana N. MicallefPatrick B. JohnstonJose C. VillasboasJonas PaludoUrshila DuraniSvetomir N. Markovic...
The human monocytic CD14+HLA-DRDIM cells are associated with worse prognosis in NHL. Thus, we investigated whether the autograft A-NKC/A-CD14+HLA-DRDIM ratio predicts survival in NHL. In a total of 111 NHL patients, we analyzed apheresis collection samples for the content of A-NKC and A...
To investigate the types of MDSCs or other myeloid cells expanded in the peripheral blood after G-CSF treatment in donors, the frequency and cell number of different MDSCs were analyzed. Total MDSCs (HLA-DR−/lowCD11b+CD33+), M-MDSCs (HLA-DR−/lowCD11b+CD33+CD14+CD15−), G-MD...
不表达:CD14,CD15,CD11b,CD4,HLA-DR,CD56,cCD79a,cCD3。 (3)CD9/CD11b/HLA-DR抗体组合在诊断APL时,具有较高的敏感性和 特异性,可作为诊断APL和监测其MRD的抗体组合。 关键词:急性早幼粒白血病;流式细胞术;免疫表型;微小残留病变 山西医科大学硕士学位论文 ...
TLR2 and TLR4 was 53 and 84% greater 1h after exercise, respectively, while HLA.DR was 48% lower. Changes in TLR2 and TLR4 expression occurred on the CD14 ++bright /CD16 +dim monocyte subtype only, while HLA.DR expression changed on the CD14 +dim /CD16 ++bright subtype. Serum did ...
Of these markers, CD11a and HLA-DR were up-regulated in the HIV+ subjects compared with controls. The expression levels of the adhesion molecules correlated with each other in both patients and controls. The CD11b (CR3-α), CD14, FcγRI, and FcγRIII markers were bimodally distributed....
65 - Infusion of Autograft Natural Killer Cells/CD14+hla-DRDIM Myeloid-Derived Suppressor Cells Ratio Predicts Survival in Non-Hodgkin Lymphoma Undergoing Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation (APHSCT)doi:10.1016/j.bbmt.2016.12.042...
These decidual CD14+ or CD14− HLA-DR+ cells have an unusual phenotype that in some respects resembles dermal myelomonocytic cells. Nonetheless, the idea that a placental monomorphic molecule could be diverting all local immune responses from immunogenic to tolerogenic is attractive. If this is ...
A humanized IgG4 anti–HLA-DR monoclonal antibody (IMMU-114), engineered to avoid side effects associated with complement activation, was examined for binding and cytotoxicity on leukemia, lymphoma, and multiple myeloma cell lines and chronic lymphocytic leukemia (CLL) patient specimens, followed by ...
Infusion of autograft natural killer cell/CD14 + HLA-DR DIM cell ratio predicts survival in lymphoma post autologous stem cell transplantationThe infusion of autograft absolute lymphocyte count (A-ALC) and autograft natural killer cells (A-NKC) are prognostic factors for overall survival (OS) and...